1. Home
  2. UGI vs PRAX Comparison

UGI vs PRAX Comparison

Compare UGI & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UGI Corporation

UGI

UGI Corporation

SELL

Current Price

$37.17

Market Cap

8.0B

Sector

Utilities

ML Signal

SELL

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

SELL

Current Price

$238.62

Market Cap

8.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
UGI
PRAX
Founded
1940
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
UGI
PRAX
Price
$37.17
$238.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
19
Target Price
$43.25
★ $644.42
AVG Volume (30 Days)
★ 1.7M
482.6K
Earning Date
11-19-2026
11-04-2026
Dividend Yield
★ 3.98%
N/A
EPS Growth
★ 147.20
N/A
EPS
★ 3.08
N/A
Revenue
★ $7,287,000,000.00
N/A
Revenue This Year
$0.79
N/A
Revenue Next Year
$5.55
$39,458.00
P/E Ratio
$12.22
★ N/A
Revenue Growth
★ 1.07
N/A
52 Week Low
$31.65
$154.46
52 Week High
$41.34
$392.70

Technical Indicators

Market Signals
Indicator
UGI
PRAX
Relative Strength Index (RSI) 50.31 22.00
Support Level $36.93 $238.77
Resistance Level $37.58 $356.02
Average True Range (ATR) 0.68 12.12
MACD 0.09 -3.04
Stochastic Oscillator 70.66 4.26

Price Performance

Historical Comparison
UGI
PRAX

About UGI UGI Corporation

UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: